Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Search Results 1-10 of 172 for IBS
IBS with diarrhea (IBS-D) has a 26 percent prevalence in the U.S.
In some cases, IBS is an ion channelopathy.
However, the mechanism of action of rifaximin in IBS remains unclear.
The cause and severity of IBS varies from person to person.
Five (2%) had unsubtyped IBS (IBS-U).
It's not unusual for people with IBS to alternate between the two.
Have a family history of IBS .
Vazquez Roque and colleagues published the results of a controlled trial of patients with IBS with diarrhea (IBS-D).
Non-IBS medications for IBS-D Given the limited number of drugs marketed specifically for IBS-D, other medications are often used to treat symptoms.
Available treatments that target constipation-predominant (IBS-C) and diarrhea-predominant IBS (IBS-D) are effective; treatments to address IBS-related pain are somewhat limited.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.